Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial

Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial

Item
http://www.wikidata.org/entity/Q34952127
Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed PatientsRaltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infectionComparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: systematic review and meta-analysis.Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patientsRaltegravir as antiretroviral therapy in HIV/AIDS.Drug safety profile of integrase strand transfer inhibitors.Integrase Strand Transfer Inhibitors in HIV Therapy.Ageing with HIV: a multidisciplinary review.Dual antiretroviral therapy for HIV infection.Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials.Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy
P2860

Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial

Item
http://www.wikidata.org/entity/Q34952127
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@ast
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@en
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@nl
type
label
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@ast
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@en
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@nl
prefLabel
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@ast
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@en
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Switching tenofovir/emtricitab ...... a randomized multicenter trial
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0073639
P407
P433
P478
P577
P698
P921
P932